Short-term effects of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor on cholesterol and bile acid synthesis in humans

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Lipids

• Publication date

  1997-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11745-997-0112-2PMID 9270980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones

  2005cited by this paper
• Cholesterol 7α - hydroxylase

  1995cited by this paper
• Biliary cholesterol secretion and bile acid formation in the hamster: the role of newly synthesized cholesterol.

  1994cited by this paper
• Determination of 7 alpha-hydroxy-4-cholesten-3-one level in plasma using isotope-dilution mass spectrometry and monitoring its circadian rhythm in human as an index of bile acid biosynthesis.

  1994cited by this paper
• Role of newly synthesized cholesterol or its metabolites on the regulation of bile acid biosynthesis after short‐term biliary diversion in the rat

  1993cited by this paper
• Bile acid synthesis from newly synthesized vs. preformed cholesterol precursor pools in the rat

  1993cited by this paper
• Simultaneous determination of mevalonate and 7 alpha-hydroxycholesterol in human plasma by gas chromatography-mass spectrometry as indices of cholesterol and bile acid biosynthesis.

  1993cited by this paper
• Bile Acid Metabolism and Its Role in Human Cholesterol Balance

  1992cited by this paper
• Effect of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia

  1992cited by this paper
• Effects of pravastatin (CS-514) on biliary lipid metabolism in patients with hyperlipidemia.

  1991cited by this paper
• Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans.

  1991influential reference
• Acute effects of HMG‐CoA reductase inhibitors on biliary lipids in patients with interrupted enterohepatic circulation

  1991influential reference
• Regulation of bile acid synthesis in humans: Effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7α‐hydroxylation rates in vivo

  1991cited by this paper
• The plasma level of 7 alpha-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7 alpha-hydroxylase in man.

  1991cited by this paper
• Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry.

  1991influential reference
• Role of cholesterol synthesis in regulation of bile acid synthesis and biliary cholesterol secretion in humans.

  1991cited by this paper
• Regulation of bile acid synthesis

  1991cited by this paper
• The plasma level of 7α‐hydroxy‐4‐cholesten‐3‐one reflects the activity of hepatic cholesterol 7α‐hydroxylase in man

  1991cited by this paper
• Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and Lovastatin

  1990cited by this paper
• Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hypercholesterolaemia.

  1990cited by this paper
• Determination of pravastatin sodium and its major metabolites in human serum/plasma by capillary gas chromatography/negative ion chemical ionization mass spectrometry.

  1989influential reference
• Effect of CS-514, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in hamsters

  1989cited by this paper
• Effect of CS-514, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in hamsters.

  1989cited by this paper
• Measurement of mevalonate in human plasma and urine by multiple selected ion monitoring.

  1989cited by this paper
• HMG-CoA reductase inhibitors for treatment of hypercholesterolemia.

  1988cited by this paper
• Levels of 7α‐hydroxy‐4‐cholesten‐3‐one in plasma reflect rates of bile acid synthesis in man

  1988cited by this paper
• Levels of 7 alpha-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man.

  1988cited by this paper
• Effects of mevinolin in rat liver: evidence for a lack of coupling between synthesis of hydroxymethylglutaryl-CoA reductase and cholesterol 7 alpha-hydroxylase activity.

  1986cited by this paper
• Role of the kidneys in the metabolism of plasma mevalonate. Studies in humans and in rhesus monkeys.

  1985cited by this paper
• Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man.

  1982cited by this paper
• Metabolism of plasma mevalonate in rats and humans.

  1982cited by this paper
• Cholesterol 7α-hydroxylase測定法とその意義

  1980cited by this paper
• Determination of mevalonate in blood plasma in man and rat. Mevalonate "tolerance" tests in man.

  1979cited by this paper
• Cholesterol 7 alpha-hydroxylase.

  1977cited by this paper
• Regulation of HMG-CoA reductase.

  1976cited by this paper
• Regulation of bile acid synthesis.

  1974cited by this paper
• Enzymatic determination of total serum cholesterol.

  1974cited by this paper
• Effect of alterations of the specific activity of the intracellular acetyl CoA pool on apparent rates of hepatic cholesterogenesis.

  1974cited by this paper
• Lipoprotein-polyanion-metal interactions.

  1973cited by this paper
• Blood concentration and turnover of circulating mevalonate in the rat.

  1972cited by this paper
• Relationship between diurnal variations in biosynthesis of cholesterol and bile acids.

  1972cited by this paper
• Effects of controlled interruption of the enterohepatic circulation of bile salts by biliary diversion and by ileal resection on bile salt secretion, synthesis, and pool size in the rhesus monkey.

  1970cited by this paper

• Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice[S]

  2014cites this paper
• Determination of Key Intermediates in Cholesterol and Bile Acid Biosynthesis by Stable Isotope Dilution Mass Spectrometry

  2008cites this paper
• Oxysterols: modulators of cholesterol metabolism and other processes.

  2000cites this paper
• Studies on Drug Metabolism by Gas Chromatography-Mass Spectrometry and it's Related Technique

  2000cites this paper
• Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones

  2000cites this paper
• Plasma levels of mevalonate and 7α‐hydroxy‐4‐cholesten‐3‐one in chronic liver disease

  1999cites this paper
• Use of cholesterol precursors to assess changes in cholesterol synthesis under non‐steady‐state conditions

  1998cites this paper